JAMA Network
About The Study: This study of buprenorphine and methadone supplies to treat opioid use disorder during the COVID-19 pandemic found a pronounced decline in the methadone supply but no disruption to the buprenorphine supply.
Authors: Bradley D. Stein, M.D., Ph.D., of the RAND Corporation in Pittsburgh, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.23708)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
